ID ARH-77 AC CVCL_1072 SY ARH 77; ARH77 DR BTO; BTO_0002992 DR CLO; CLO_0001744 DR CLO; CLO_0001745 DR EFO; EFO_0002111 DR CLDB; cl285 DR ArrayExpress; E-MTAB-38 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-3610 DR ATCC; CRL-1621 DR BCRC; 60385 DR BioGRID_ORCS_Cell_line; 831 DR BioSample; SAMN03471407 DR CCRID; 4201HUM-CCTCC00218 DR CCTCC; GDC0218 DR Cell_Model_Passport; SIDM00900 DR ChEMBL-Cells; CHEMBL3308536 DR ChEMBL-Targets; CHEMBL2366241 DR CLS; 300306 DR Cosmic; 759914 DR Cosmic; 886086 DR Cosmic; 888020 DR Cosmic; 906765 DR Cosmic; 919148 DR Cosmic; 999792 DR Cosmic-CLP; 906765 DR DepMap; ACH-002210 DR DSMZ; ACC-512 DR DSMZCellDive; ACC-512 DR ECACC; 88121201 DR EGA; EGAS00001000978 DR FANTOM5_SSTAR; 10840-111E3 DR GDSC; 906765 DR GEO; GSM1374393 DR GEO; GSM1669601 DR IARC_TP53; 21176 DR IGRhCellID; ARH77 DR LINCS_LDP; LCL-2041 DR Lonza; 593 DR PharmacoDB; ARH77_64_2019 DR PubChem_Cell_line; CVCL_1072 DR Wikidata; Q54750440 RX DOI=10.1007/0-306-46877-8_4; RX Patent=US4730036; RX PubMed=566614; RX PubMed=2140233; RX PubMed=2985879; RX PubMed=3159941; RX PubMed=3874327; RX PubMed=4042077; RX PubMed=6605913; RX PubMed=7140810; RX PubMed=7579375; RX PubMed=8051085; RX PubMed=9510473; RX PubMed=10516762; RX PubMed=10936422; RX PubMed=14555701; RX PubMed=18262052; RX PubMed=20164919; RX PubMed=20215515; RX PubMed=20454443; RX PubMed=27397505; RX PubMed=30894373; RX PubMed=30971826; WW Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-morphology-for-atcc-crl-1621 CC Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=4042077; PubMed=7579375; PubMed=10516762). CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Population: Caucasian. CC Doubling time: 110.4 hours (PubMed=566614); ~30 hours (DSMZ=ACC-512). CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (Cosmic-CLP=906765). CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; CRISPR screening. CC Omics: Phenotyping; Drug screening. CC Omics: Transcriptomics; Microarray. CC Omics: Variations; Array-based CGH. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=2.24%; Native American=0.38%; East Asian, North=0%; East Asian, South=2.18%; South Asian=8.63%; European, North=25.32%; European, South=61.25% (PubMed=30894373). CC Misspelling: AHR 77; Note=Occasionally. CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: B-cell; CL=CL_0000236. ST Source(s): ATCC=CRL-1621; CLS=300306; Cosmic-CLP=906765; DSMZ=ACC-512; ECACC=88121201 ST Amelogenin: X ST CSF1PO: 6,10 ST D12S391: 19,20 ST D13S317: 11,13 ST D16S539: 9,13 ST D18S51: 14,16 ST D19S433: 14,15 ST D21S11: 29,30 ST D2S1338: 17 ST D3S1358: 16 ST D5S818: 10,13 ST D6S1043: 11,19 ST D7S820: 7,12 ST D8S1179: 14,15 ST FGA: 20,21 ST Penta D: 10 ST Penta E: 12 ST TH01: 8,9.3 ST TPOX: 8 ST vWA: 17 OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 33Y CA Transformed cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 43 CH CVCL_A5YK ! ARH-77 clone A5P3 CH CVCL_8119 ! HMy.2 B // RX PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2; RA Drexler, Hans Gunther RA Matsuo, Yoshinobu RT "Malignant hematopoietic cell lines: in vitro models for the study of RT multiple myeloma and plasma cell leukemia."; RL Leuk. Res. 24:681-703(2000). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=4042077; DOI=10.1002/1097-0142(19851115)56:10<2544::AID-CNCR2820561039>3.0.CO;2-G; RA Ralph, Peter RT "The human B-cell lineage cell line ARH-77."; RL Cancer 56:2544-2545(1985). // RX PubMed=18262052; DOI=10.1016/j.cancergencyto.2007.10.013; RA Parker, Helen RA Cheung, Kan Luk RA Robinson, Hazel M. RA Harrison, Christine Joyce RA Strefford, Jonathan C. RT "Cytogenetic and genomic characterization of cell line ARH77."; RL Cancer Genet. Cytogenet. 181:40-45(2008). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- 1. RT Carboxylic esterase."; RL Leuk. Res. 9:209-229(1985). // RX DOI=10.1007/0-306-46877-8_4; RA Jernberg-Wiklund, Helena RA Nilsson, Kenneth RT "Multiple myeloma cell lines."; RL (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000). // RX PubMed=566614; RA Burk, Kenneth H. RA Drewinko, Benjamin RA Trujillo, Jose M. RA Ahearn, Michael John RT "Establishment of a human plasma cell line in vitro."; RL Cancer Res. 38:2508-2513(1978). // RX PubMed=2140233; DOI=10.1111/j.1440-1827.1990.tb01549.x; RA Nakano, Akinobu RA Harada, Takayuki RA Morikawa, Shigeru RA Kato, Yuzuru RT "Expression of leukocyte common antigen (CD45) on various human RT leukemia/lymphoma cell lines."; RL Acta Pathol. Jpn. 40:107-115(1990). // RX PubMed=30971826; DOI=10.1038/s41586-019-1103-9; RA Behan, Fiona M. RA Iorio, Francesco RA Picco, Gabriele RA Goncalves, Emanuel RA Beaver, Charlotte M. RA Migliardi, Giorgia RA Santos, Rita RA Rao, Yanhua RA Sassi, Francesco RA Pinnelli, Marika RA Ansari, Rizwan RA Harper, Sarah RA Jackson, David Adam RA McRae, Rebecca RA Pooley, Rachel RA Wilkinson, Piers RA van der Meer, Dieudonne J. RA Dow, David RA Buser-Doepner, Carolyn A. RA Bertotti, Andrea RA Trusolino, Livio RA Stronach, Euan Alexander RA Saez-Rodriguez, Julio RA Yusa, Kosuke RA Garnett, Mathew J. RT "Prioritization of cancer therapeutic targets using CRISPR-Cas9 RT screens."; RL Nature 568:511-516(2019). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX PubMed=6605913; DOI=10.1016/0165-2478(83)90049-4; RA Ralph, Peter RA Saiki, Osamu RA Maurer, David H. RA Welte, Karl RT "IgM and IgG secretion in human B-cell lines regulated by RT B-cell-inducing factors (BIF) and phorbol ester."; RL Immunol. Lett. 7:17-23(1983). // RX PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cell lines -- III. RT Beta-hexosaminidase (E.C. 3.2.1.30)."; RL Leuk. Res. 9:549-559(1985). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x; RA Drexler, Hans Gunther RA Gaedicke, Gerhard RA Minowada, Jun RT "Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid RT phosphatase."; RL Leuk. Res. 9:537-548(1985). // RX PubMed=20454443; DOI=10.1155/2010/904767; PMCID=PMC2861168; RA Uphoff, Cord C. RA Denkmann, Sabine A. RA Steube, Klaus G. RA Drexler, Hans Gunther RT "Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human RT and other primate cell lines."; RL J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010). // RX PubMed=7579375; DOI=10.1182/blood.V86.10.4001.bloodjournal86104001; RA Pellat-Deceunynck, Catherine RA Amiot, Martine RA Bataille, Francois-Regis RA Van Riet, Ivan RA Van Camp, Benjamin RA Omede, Paola RA Boccadoro, Mario RT "Human myeloma cell lines as a tool for studying the biology of RT multiple myeloma: a reappraisal 18 years after."; RL Blood 86:4001-4002(1995). // RX Patent=US4730036; RA Ralph, Peter RA Welte, Karl RT "Purifications of B-cell inducing factor (BIF) and B-cell growth RT factor (BGF)."; RL Patent number US4730036, 08-Mar-1988. // RX PubMed=14555701; RA Shammas, Masood A. RA Shmookler Reis, Robert Joseph RA Akiyama, Masaharu RA Koley, Hemanta RA Chauhan, Dharminder RA Hideshima, Teru RA Goyal, Raj K. RA Hurley, Laurence H. RA Anderson, Kenneth Carl RA Munshi, Nikhil C. RT "Telomerase inhibition and cell growth arrest by G-quadruplex RT interactive agent in multiple myeloma."; RL Mol. Cancer Ther. 2:825-833(2003). // RX PubMed=10516762; DOI=10.1038/sj.leu.2401510; RA Drexler, Hans Gunther RA Dirks, Wilhelm Gerhard RA MacLeod, Roderick A.F. RT "False human hematopoietic cell lines: cross-contaminations and RT misinterpretations."; RL Leukemia 13:1601-1607(1999). // RX PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x; PMCID=PMC5921588; RA Hosoya, Noriko RA Hangaishi, Akira RA Ogawa, Seishi RA Miyagawa, Kiyoshi RA Mitani, Kinuko RA Yazaki, Yoshio RA Hirai, Hisamaru RT "Frameshift mutations of the hMSH6 gene in human leukemia cell RT lines."; RL Jpn. J. Cancer Res. 89:33-39(1998). // RX PubMed=7140810; DOI=10.1002/eji.1830120804; RA Edwards, Paul A.W. RA Smith, Carissa M. RA Neville, Alexander Munro RA O'Hare, Michael J. RT "A human-hybridoma system based on a fast-growing mutant of the ARH-77 RT plasma cell leukemia-derived line."; RL Eur. J. Immunol. 12:641-648(1982). // RX PubMed=8051085; DOI=10.1016/S0021-9258(17)32120-8; RA Liebersbach, Brian F. RA Sanderson, Ralph D. RT "Expression of syndecan-1 inhibits cell invasion into type I RT collagen."; RL J. Biol. Chem. 269:20013-20019(1994). //